MedPath

Artificial Intelligence-assisted Diagnosis

Active, not recruiting
Conditions
Congenital Heart Disease (CHD)
Structural Heart Disease
Registration Number
NCT06783933
Lead Sponsor
China National Center for Cardiovascular Diseases
Brief Summary

This study aims to investigate whether an AI-assisted decision support can improve the diagnosis of congenital heart diseases on Chest X-ray.

Detailed Description

Congenital heart disease (CHD) is a structural abnormality of the heart and/or great vessels and the frequency of CHD is nearly 1% in general population. In clinical practice, Chest X-ray is an important routine method for detection of CHD. However, its learning curve is high. Based on Chest X-ray, Artificial intelligence (AI) has the potential to improve the efficiency and accuracy of CHD. This study aims to investigate whether an AI-assisted decision support can improve the diagnosis of congenital heart diseases on Chest X-ray.

This study will enroll subjects with CHD, and the enrollment will be divided into two phases.

Phase 1: Previous data of chest X-ray in patients with CHD. A minimum of 3000 patients is reached.

Phase 2: Prospective inclusion of general patients with chest X-ray. A minimum of 5000 patients is reached.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
8000
Inclusion Criteria
  1. Chest X-ray of patients with ASD;
  2. Chest X-ray of patients with VSD;
  3. Chest X-ray of patients with PDA;
  4. Chest X-ray of patients with PFO;
  5. Chest X-ray of patients with PS;
  6. Chest X-ray of patients with TOF/PAA;
  7. Chest X-ray of patients with MS;
  8. Chest X-ray of patients with other heart diseases;
Exclusion Criteria
  1. CHD Patients without surgical, interventional validation;
  2. Serious Scoliosis;
  3. Pulmonary inflammation or consolidation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
accuracy with AI-assisted diagnosis12 months

Number of subjects with accuracy of CHD ; based on surgical validation or interventional validation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fuwai hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath